Health Canada Oks Clinical-Grade MDMA Export To UK
Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its manufacturing partners received a Health Canada export permit for no less than 300 grams of proprietary MDMA LaNeo.
"We're incredibly proud of this milestone. It is additional proof that the clinical development of MDMA is moving forward. PharmAla exists to assist our client researchers around the world by not only saying we'll provide them with research materials, but actually delivering." said CEO Nick Kadysh.
The MDMA is destined for a UK-based client who will use the materials for research...
Login or create a forever free account to read this news
Sign up/Log in